Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives

Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives

Item
http://www.wikidata.org/entity/Q26865233
Targeting heart failure with preserved ejection fraction: current status and future prospectsEmerging Metabolic Therapies in Pulmonary Arterial Hypertension.Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fractionSIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionCentral cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fractionManagement of pulmonary hypertension due to heart failure with preserved ejection fraction.Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications.Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.Prevalence and etiologies of pulmonary hypertension in Africa: a systematic review and meta-analysis.Impact of the 2016 ASE/EACVI recommendations on the prevalence of diastolic dysfunction in the general population.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.ECMO cannulation strategy for pulmonary hypertension: an alternative approach to traditional Veno-Arterial ECMO.Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.Self-reported functional status predicts post-operative outcomes in non-cardiac surgery patients with pulmonary hypertension
P2860

Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives

Item
http://www.wikidata.org/entity/Q26865233
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@ast
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@en
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@nl
type
label
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@ast
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@en
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@nl
prefLabel
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@ast
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@en
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P698
P921
P3181
P356
P1433
P1476
Pulmonary hypertension in hear ...... ogy, and clinical perspectives
@en
P2093
P304
P31
P3181
P356
10.1161/CIRCHEARTFAILURE.113.000823
P407
P433
P478
P50
P577
P698
P921